Chemed Profit Margin 2010-2025 | CHE

Current and historical gross margin, operating margin and net profit margin for Chemed (CHE) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Chemed net profit margin as of March 31, 2025 is 12.4%.
Chemed Annual Profit Margins
Chemed Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.428B $2.431B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.823B 19.53
Encompass Health (EHC) United States $11.724B 24.85
DaVita (DVA) United States $10.882B 14.45
Option Care Health (OPCH) United States $5.373B 23.95
Elanco Animal Health (ELAN) United States $4.791B 10.60
RadNet (RDNT) United States $3.985B 84.33
Amedisys (AMED) United States $3.159B 21.25
LifeStance Health (LFST) United States $2.574B 0.00
Addus HomeCare (ADUS) United States $1.920B 21.08
Astrana Health (ASTH) United States $1.816B 36.39
U.S Physical Therapy (USPH) United States $1.097B 28.00
Pennant (PNTG) United States $0.928B 37.14
Aveanna Healthcare Holdings (AVAH) United States $0.925B 0.00
Atai Life Sciences (ATAI) Germany $0.294B 0.00
Daxor (DXR) United States $0.035B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.004B 0.00
Psychemedics (PMD) United States $0.000B 0.00